Get started
Author

Karin M Durant

Observed name: Karin Durant
ORCID: 0000-0002-3646-7310
Observed ORCID: 0000-0002-3646-7310
OpenAlex ID: A5004451343
Insights on developing a field hospital formulary and medication distribution process in preparation for a second surge of COVID-19 cases
2020 · Brian Bazzell, Deb Wagner, et al. · American Journal of Health-System Pharmacy · 6
PDF
Impact of an electronic health record alert on inappropriate prescribing of high-risk medications to patients with concurrent “do not give” orders
2022 · Kirsten Smith, Karin M Durant, et al. · American Journal of Health-System Pharmacy · 4
Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura
2020 · Justin H Reid, Karin M Durant, et al. · Journal of Oncology Pharmacy Practice · 4
Artificial intelligence for drug information: Evaluating its use in real-world pharmacy practice
2025 · Allison Frazer, Emily Yoon, et al. · American Journal of Health-System Pharmacy · 2
ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting
2025 · Karin Durant, Julie Gwin, et al. · American Journal of Health-System Pharmacy · 2
A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics
2024 · Karin M Durant, Ashlyn Whitesell, et al. · American Journal of Health-System Pharmacy · 1
Intermittent versus continuous intravenous epoprostenol for the treatment of digital ischemia
2024 · Sarah Alsomairy, Kristen T Pogue, et al. · Journal of Scleroderma and Related Disorders
PDF
Works count: 7
Citation count: 19
H-index: 3
I10-index:
Year
Topic
Type